| abstract |
The present invention relates to compounds of formula (I): (Wherein R 1, R 2 and R 3 are defined in the detailed description) and base-added salts thereof with pharmaceutically acceptable organic or inorganic bases thereof. The present invention also relates to a process for preparing the same, an intermediate for preparing the same, and a pharmaceutical composition comprising the same. The invention also relates to the use of the novel 2H-pyrrolo [3,4-c] quinoline compounds for the preparation of pharmaceutical compositions effective for the treatment of disorders of the serotonin system. |